Phreesia Named Top Place to Work in Healthcare for 2026

Paysign, Inc. reported a 40.5% increase in full-year 2025 revenues to $82 million, driven by a 4% increase in plasma revenue and a 168% increase in pharma revenue. The company's net income for the year was $7.55 million, or $0.13 per diluted share, up from $3.82 million in 2024. Adjusted EBITDA increased by 107.3% to $19.94 million, and the effective tax rate was 24.7%. Paysign exited the year with $21.07 million in unrestricted cash and zero debt.